FDA approved the first Home COVID-19 Test Kit
- Swollen axillary lymph nodes associated with the COVID-19 vaccine last longer than initially reported
- How to relieve the fatigue symptoms of patients with Parkinson’s disease?
- Frontiers in Oncology: Mushroom extract can clear HPV infection
- Study estimates COVID-19 vaccine saved nearly 20 million lives last year
- Pfizer invests nearly US$100 million in Valneva to accelerate Lyme disease vaccine
- Cancer cells can metastasize faster while patients are sleeping
FDA approved the first Home COVID-19 Test Kit
FDA approved the first Home COVID-19 Test Kit. On December 9, local time, the U.S. Food and Drug Administration (FDA) approved the emergency use authorization for the first batch of non-prescription COVID-19 test kits for home use.
The U.S. Food and Drug Administration said at a press conference on the 9th that LabCorp’s home collection kit product Pixel for the detection of COVID-19 virus allows all people over 18 to purchase it. Testers can send nasal swab samples after collecting them at home Send to the relevant organization of LabCorp for testing.
After the test is completed, the positive or invalid results will be reported back to the tester via the phone or the healthcare provider. If the result is negative, the tester will be notified via email or official website.
The U.S. Food and Drug Administration said that the kit can help people understand their health at any time and determine whether and when they need to self-isolate. After discussing with healthcare providers, its test results can also help testers make healthcare decisions.
LabCorp also emphasized that the new home test kit cannot replace the doctor’s visit, and it is recommended that people still focus on the doctor’s diagnosis.
Gutentor Simple Text
Gutentor Simple Text
